Sanara MedTech Dips After Swing to Profit
Sanara MedTech shares fell 2.1% to $22.69 Tuesday morning, underperforming a rising U.S. market. The company last reported Q1 revenue up 19% to $27.8 million and returned to profit, but cash dropped to $13.6 million and long-term debt stood at $46.2 million. No new updates were issued Tuesday. About 4,000 shares traded by late morning.
